Adam advises in all areas of life-science and especially in biotechnological, medicinal, and diagnostic technologies involving stem cells, antibodies, nucleic acids, vaccines, and peptides. He has a background in molecular biology with a focus on epigenetics and disease.
Adam is experienced in working with universities, start-ups, and large firms, and has expertise in evaluating patentability, freedom to operate analyses, and drafting and prosecuting patent applications before the EPO.
University of Barcelona (B.Sc. Plant Biology, 2008)
University of California, Irvine (M.Sc. Biotechnology, 2010)
Copenhagen University (BRIC, Ph.D. Health & Medical Sciences, 2014)
English, Danish, French, Spanish, Catalan.